NAQUASONE DIN 00555673
Health Canada record
| Active ingredient(s) | TRICHLORMETHIAZIDE 10 MG; DEXAMETHASONE ACETATE 0.55 MG |
|---|---|
| Dosage form | Solution |
| Route | Intramuscular |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Veterinary |
| ATC | |
| Original market date | 31-Dec-1982 |
| Current status date | 13-Sep-2013 |
| Source | Health Canada DPD |
Establishment licence of the holder
Intervet Canada Corp. — licence 100147, currently licensed, last inspection rating C (2023-07-17).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TRICHLORMETHIAZIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00176982 | NAQUASONE | INTERVET CANADA CORP | Bolus | TRICHLORMETHIAZIDE 200 MG; DEXAMETHASONE 5 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 34722 | 2025-01-23 | Supplement to a New Drug Submission (SNDS) | Labelling update - removal of the reference NAQUASONE BOLUS |
| 10851 | 2009-12-11 | New Drug Submission (NDS) | Change in ownership |
International API supply for TRICHLORMETHIAZIDE
0 active FDA Drug Master Files.
Request a quote for NAQUASONE